Illumina INC:1107104 [17-051908]

Ended Awarded Last action

Contract number
HHSN26100081
Awardee
Awarding agency
Obligated
$22,188

Award facts

Opportunity
  • NIHNHLBICSBHG2015RF Solicitation number
Contract value 100% obligated
$22,188.47 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute issued a delivery order to Illumina, Inc. on July 26, 2017, with a ceiling value of $22,188.47 for genetic sequencing equipment and consumables, with ultimate completion by August 28, 2017.

Place of performance is Bethesda, MD. The order is firm fixed price with no set-aside designation. Illumina specializes in DNA and RNA sequencing instruments, reagents, and bioinformatics software supporting genomic research across federal agencies.

Quick answers

Who was awarded contract HHSN26100081?

HHSN26100081 was awarded to Illumina, Inc. by National Cancer Institute (National Institutes of Health) on July 26, 2017.

How much is contract HHSN26100081 worth?

The government has obligated $22,188 on HHSN26100081.

Is contract HHSN26100081 an order under another contract?

Yes. HHSN26100081 is a delivery order under HHSN268201500004I, an indefinite delivery contract.

Was contract HHSN26100081 competed?

The extent of competition for HHSN26100081 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award